EGR2 and B-cell chronic lymphocytic leukemia: Recurrent mutations such as NOTCH1, MYC, SF3B1, BRAF, TP53, XPO1, MED12, NFKBIE, and EGR2 are commonly seen in various subsets of CLL patients (14, 29, 92–95).